Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

被引:96
|
作者
Sissung, Tristan M. [2 ]
Baum, Caitlin E. [1 ]
Kirkland, C. Tyler [1 ]
Gao, Rui [1 ]
Gardner, Erin R. [3 ]
Figg, William D. [1 ,2 ]
机构
[1] NCI, Mol Pharmacol Sect, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[2] NCI, Clin Pharmacol Program, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[3] NCI, Clin Pharmacol Program, SAIC Frederick, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
ABCB1; ABCC1; ABCC2; ABCG2; OATP1B3; OATP1B1; Pharmacogenetics; Membrane transporters; SINGLE NUCLEOTIDE POLYMORPHISMS; CANCER RESISTANCE PROTEIN; HUMAN MDR1 GENE; OATP1B1; OATP-C; P-GLYCOPROTEIN; ORGANIC ANION; IN-VITRO; ORAL BIOAVAILABILITY; FUNCTIONAL-CHARACTERIZATION; MULTIDRUG TRANSPORTERS;
D O I
10.1007/s12033-009-9220-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review provides an overview of the pharmacogenetics of membrane transporters including selected ABC transporters (ABCB1, ABCC1, ABCC2, and ABCG2) and OATPs (OATP1B1 and OATP1B3). Membrane transporters are heavily involved in drug clearance and alters drug disposition by actively transporting substrate drugs between organs and tissues. As such, polymorphisms in the genes encoding these proteins may have significant effects on the absorption, distribution, metabolism and excretion of compounds, and may alter pharmacodynamics of many agents. This review discusses the techniques used to identify substrates and inhibitors of these proteins and subsequently to assess the effect of genetic mutation on transport, both in vitro and in vivo. A comprehensive list of substrates for the major drug transporters is included. Finally, studies linking transporter genotype with clinical outcomes are discussed.
引用
收藏
页码:152 / 167
页数:16
相关论文
共 50 条
  • [1] Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
    Tristan M. Sissung
    Caitlin E. Baum
    C. Tyler Kirkland
    Rui Gao
    Erin R. Gardner
    William D. Figg
    Molecular Biotechnology, 2010, 44 : 152 - 167
  • [2] Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy
    Ying Huang
    Cancer and Metastasis Reviews, 2007, 26 : 183 - 201
  • [3] Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy
    Huang, Ying
    CANCER AND METASTASIS REVIEWS, 2007, 26 (01) : 183 - 201
  • [4] Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
    Miriam G. Mooij
    Anne T. Nies
    Catherijne A. J. Knibbe
    Elke Schaeffeler
    Dick Tibboel
    Matthias Schwab
    Saskia N. de Wildt
    Clinical Pharmacokinetics, 2016, 55 : 507 - 524
  • [5] Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
    Mooij, Miriam G.
    Nies, Anne T.
    Knibbe, Catherijne A. J.
    Schaeffeler, Elke
    Tibboel, Dick
    Schwab, Matthias
    de Wildt, Saskia N.
    CLINICAL PHARMACOKINETICS, 2016, 55 (05) : 507 - 524
  • [6] Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation
    Camille Tron
    Florian Lemaitre
    Céline Verstuyft
    Antoine Petitcollin
    Marie-Clémence Verdier
    Eric Bellissant
    Clinical Pharmacokinetics, 2019, 58 : 593 - 613
  • [7] Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation
    Tron, Camille
    Lemaitre, Florian
    Verstuyft, Celine
    Petitcollin, Antoine
    Verdier, Marie-Clemence
    Bellissant, Eric
    CLINICAL PHARMACOKINETICS, 2019, 58 (05) : 593 - 613
  • [8] Pharmacogenetics of drug transporters
    Danesi, R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 14 - 14
  • [9] Pharmacogenetics of Drug Transporters
    Franke, R. M.
    Gardner, E. R.
    Sparreboom, A.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (02) : 220 - 230
  • [10] Pharmacogenetics of monoamine transporters
    Glatt, CE
    Reus, VI
    PHARMACOGENOMICS, 2003, 4 (05) : 583 - 596